High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance

by Karin Neukam, Yusnelkis Milanés Guisado, María Fontillón, Laura Merino, César Sotomayor, Nuria Espinosa, Luis F. López-Cortés, Pompeyo Viciana
Published 2019-06-01

Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients.

by Sara Corchado, Luis F López-Cortés, Antonio Rivero-Juárez, Almudena Torres-Cornejo, Antonio Rivero, Mercedes Márquez-Coello, José-Antonio Girón-González
Published 2014-01-01

HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors

by Esperanza Muñoz-Muela, María Trujillo-Rodríguez, Ana Serna-Gallego, Abraham Saborido-Alconchel, Ezequiel Ruiz-Mateos, Luis F. López-Cortés, Alicia Gutiérrez-Valencia
Published 2023-12-01

<em>Enterococcus faecalis</em> Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives

by Laura Herrera-Hidalgo, Arístides de Alarcón, Luis E. López-Cortes, Rafael Luque-Márquez, Luis F. López-Cortes, Alicia Gutiérrez-Valencia, María V. Gil-Navarro
Published 2020-09-01

Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.

by Juan Macías, Luis F López-Cortés, Francisco Téllez, Eva Recio, Guillermo Ojeda-Burgos, Maria José Ríos, Antonio Rivero-Juárez, Marcial Delgado, Rivas-Jeremías, Juan A Pineda
Published 2015-01-01

HCV viral decline at week 2 of Peg-IFN-alpha-2a/RBV therapy as a predictive tool for tailoring treatment in HIV/HCV genotype 1 co-infected patients.

by Antonio Rivero-Juarez, Luis F López-Cortés, Angela Camacho, Almudena Torres-Cornejo, Ana Gordon, Rosa Ruiz-Valderas, Julian Torre-Cisneros, Juan A Pineda, Pompeyo Viciana, Antonio Rivero
Published 2014-01-01

Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients.

by Antonio Rivero-Juárez, Luis F Lopez-Cortes, Angela Camacho, Almudena Torres-Cornejo, Juan A Pineda, Manuel Marquez-Solero, Antonio Caruz, Rosa Ruiz-Valderas, Julian Torre-Cisneros, Alicia Gutierrez-Valencia, Antonio Rivero
Published 2012-01-01

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered

by Luis F. López-Cortés, Abraham Saborido-Alconchel, María Trujillo-Rodríguez, Ana Serna-Gallego, Silvia Llaves-Flores, Esperanza Muñoz-Muela, María Jesús Pérez-Santos, Carmen Lozano, Marta Mejias-Trueba, Marta Mejias-Trueba, Cristina Roca, Nuria Espinosa, Alicia Gutiérrez-Valencia
Published 2023-03-01

Mesenchymal stromal cells in human immunodeficiency virus‐infected patients with discordant immune response: Early results of a phase I/II clinical trial

by María Trujillo‐Rodríguez, Pompeyo Viciana, Inmaculada Rivas‐Jeremías, Ana I. Álvarez‐Ríos, Antonio Ruiz‐García, Olga Espinosa‐Ibáñez, Salvador Arias‐Santiago, Juliana Martínez‐Atienza, Rosario Mata, Olga Fernández‐López, Ezequiel Ruiz‐Mateos, Alicia Gutiérrez‐Valencia, Luis F. López‐Cortés
Published 2021-04-01

Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients.

by Luis F López-Cortés, Rosa Ruiz-Valderas, Luis Jimenez-Jimenez, María F González-Escribano, Almudena Torres-Cornejo, Rosario Mata, Antonio Rivero, Juan A Pineda, Manuel Marquez-Solero, Pompeyo Viciana, Grupo para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas
Published 2012-01-01

Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.

by Karin Neukam, Daniela I Munteanu, Antonio Rivero-Juárez, Thomas Lutz, Jan Fehr, Mattias Mandorfer, Sanjay Bhagani, Luis F López-Cortés, Annette Haberl, Marcel Stoeckle, Manuel Márquez, Stefan Scholten, Ignacio de Los Santos-Gil, Stefan Mauss, Antonio Rivero, Antonio Collado, Marcial Delgado, Juergen K Rockstroh, Juan A Pineda
Published 2015-01-01

Clinical and virological efficacy of etravirine plus two active Nucleos(t)ide analogs in an heterogeneous HIV-infected population.

by Luis F López-Cortés, Pompeyo Viciana, José A Girón-González, Alberto Romero-Palacios, Manuel Márquez-Solero, Maria A Martinez-Perez, Miguel A López-Ruz, Javier de la Torre-Lima, Francisco Téllez-Pérez, Marcial Delgado-Fernández, Milagros Garcia-Lázaro, Fernando Lozano, Mohamed O Mohamed-Balghata, Sociedad Andaluza de Enfermedades Infecciosas
Published 2014-01-01

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

by Laia Reverté, Elena Yeregui, Montserrat Olona, Alicia Gutiérrez‐Valencia, Maria José Buzón, Anna Martí, Frederic Gómez‐Bertomeu, Teresa Auguet, Luis F. López‐Cortés, Joaquin Burgos, Clara Benavent‐Bofill, Carme Boqué, Graciano García‐Pardo, Ezequiel Ruiz‐Mateos, Maria Teresa Mestre, Francesc Vidal, Consuelo Viladés, Joaquim Peraire, Anna Rull, COVIDOMICS Study Group
Published 2022-01-01

Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypesResearch in context

by Maria R. Jimenez-Leon, Carmen Gasca-Capote, Laura Tarancon-Diez, Beatriz Dominguez-Molina, Macarena Lopez-Verdugo, Ryan Ritraj, Isabel Gallego, Ana I. Alvarez-Rios, Joana Vitalle, Sara Bachiller, María Inés Camacho-Sojo, Alberto Perez-Gomez, Nuria Espinosa, Cristina Roca-Oporto, Mohamed Rafii-El-Idrissi Benhnia, Alicia Gutierrez-Valencia, Luis F. Lopez-Cortes, Ezequiel Ruiz-Mateos
Published 2023-05-01

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens.

by Luis F López-Cortés, Manuel A Castaño, Miguel A López-Ruz, María J Rios-Villegas, José Hernández-Quero, Dolores Merino, Patricia Jiménez-Aguilar, Manuel Marquez-Solero, Alberto Terrón-Pernía, Francisco Tellez-Pérez, Pompeyo Viciana, Francisco Orihuela-Cañadas, Zaira Palacios-Baena, David Vinuesa-Garcia, Jose M Fajardo-Pico, Alberto Romero-Palacios, Guillermo Ojeda-Burgos, Juan Pasquau-Liaño
Published 2016-01-01

Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response

by Alberto Pérez‐Gómez, Carmen Gasca‐Capote, Joana Vitallé, Francisco J. Ostos, Ana Serna‐Gallego, María Trujillo‐Rodríguez, Esperanza Muñoz‐Muela, Teresa Giráldez‐Pérez, Julia Praena‐Segovia, María D. Navarro‐Amuedo, María Paniagua‐García, Manuel García‐Gutiérrez, Manuela Aguilar‐Guisado, Inmaculada Rivas‐Jeremías, María Reyes Jiménez‐León, Sara Bachiller, Alberto Fernández‐Villar, Alexandre Pérez‐González, Alicia Gutiérrez‐Valencia, Mohammed Rafii‐El‐Idrissi Benhnia, Daniela Weiskopf, Alessandro Sette, Luis F. López‐Cortés, Eva Poveda, Ezequiel Ruiz‐Mateos, Virgen del Rocío Hospital COVID‐19 and COHVID‐GS Working Teams
Published 2022-04-01